Sign In
Buy DXCM
$86.94
-0.370 (-0.424%)
At Close: Aug 04, 2026
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried
12:17pm, Monday, 10'th Mar 2025
Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S. The post Why Dexcom Is On A Six-Day Losing Spree — But This An
Analysts Say 6 Rising Stocks Are Your Best Bets Amid Trump
08:00am, Monday, 10'th Mar 2025
It might be tempting to pull your money out of the S&P 500 given President Trump's trade-war mongering. The post Analysts Say 6 Rising Stocks Are Your Best Bets Amid Trump appeared first on Investor's
Dexcom receives FDA warning letter for two U.S. manufacturing facilities
05:52pm, Friday, 07'th Mar 2025
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key manufacturing facilities, sending its shares down near
DexCom, Inc. (DXCM) Presents at 46th Annual Raymond James Institutional Investors Brokers Conference (Transcript)
01:13pm, Tuesday, 04'th Mar 2025
DexCom, Inc. (NASDAQ:DXCM ) 46th Annual Raymond James Institutional Investors Conference March 4, 2025 10:25 AM ET Company Participants Jereme Sylvain - Chief Financial Officer Matt Carey - Manager of
3 Growth Stocks to Buy and Hold Forever
06:14pm, Saturday, 01'st Mar 2025
The best way to grow your wealth and better prepare yourself for retirement is to accumulate shares of solid growth stocks to own for the long term. As these companies steadily grow their revenue and
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
04:32am, Wednesday, 26'th Feb 2025
Healthcare is considered a defensive industry, since good medical care is needed regardless of economic or market conditions. Therefore many companies in this sector are somewhat insulated from the im
Quality Key in Volatile Market, NFLX & DXCM Value Plays
03:48pm, Friday, 21'st Feb 2025
Friday's trading session showed weakness is possible in the current market, and Lisa Schreiber says investors need to turn to quality in a time of volatility. Lisa expects the U.S. economy to bolster
4 Seniors & Aging Demographics Stocks to Watch Right Now
12:10pm, Friday, 21'st Feb 2025
ABBV, AMGN, SYK and DXCM are well-poised to benefit from the evolving new opportunities in Seniors & Aging Demographics within healthcare.
NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight
01:36pm, Tuesday, 18'th Feb 2025
ILMN, IQV and DXCM are leveraging AI advancements to drive innovation in genomics, clinical research and diabetes management.
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
03:04pm, Friday, 14'th Feb 2025
On Thursday, Dexcom, Inc.'s DXCM fourth-quarter revenue rose 8% year-over-year to $1.114 billion, beating the analyst consensus estimate of $1.104 billion.
DexCom Analysts Increase Their Forecasts After Q4 Earnings
09:22am, Friday, 14'th Feb 2025
DexCom, Inc. DXCM reported weaker-than-expected earnings for its fourth quarter on Thursday.
DexCom Stock Rises Despite Q4 Earnings Miss & Lower Margins
07:56am, Friday, 14'th Feb 2025
DXCM's fourth-quarter 2024 earnings decline despite increasing sales. Its performance in 2025 is expected to be fueled by global growth in CGM adoption, strong Sensor sales and expansion into new mark
DexCom, Inc. (DXCM) Q4 2024 Earnings Call Transcript
09:33pm, Thursday, 13'th Feb 2025
DexCom, Inc. (NASDAQ:DXCM ) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Sean Christensen - Vice President of Finance and Investor Relations Kevin Sayer - Chairma
DexCom: Revenue Up, EPS Misses Mark
07:02pm, Thursday, 13'th Feb 2025
DexCom (DXCM 0.26%), known for its continuous glucose monitoring (CGM) systems, recently unveiled its Q4 2024 earnings report on Feb. 13, 2025. This release highlighted an 8% growth in revenue, which
Here's What Key Metrics Tell Us About DexCom (DXCM) Q4 Earnings
06:30pm, Thursday, 13'th Feb 2025
The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estima
